Gluten-free, casein-free diet

Since the 1990s, dietary approaches have increasingly been considered by some as complementary to therapeutic care in autism. Among these, gluten and casein-free diets have gained popularity, particularly among parents of autistic children in France, These diets have been widely adopted since the early 2000s despite the lack of scientific evidence supporting their effectiveness. The proliferation of such dietary interventions has occurred in a broader context of conflicting and abundant nutritional information. According to Jean-Louis Schlienger, honorary professor at the Faculty of Medicine of the University of Strasbourg, restrictive diets excluding products such as gluten, dairy, or meat lack a scientific basis at the population level and contradict established principles of dietary balance and diversity. Critics of these approaches, including Dr. Julie Dachez, argue that some proponents of exclusion diets and other so-called biomedical treatments for autism take advantage of parental anxiety by offering unproven solutions at significant financial cost. Families often implement exclusion diets for autistic children based on personal testimonies, frequently found online, to alleviate autism-related symptoms. The popularity of such diets may be partly linked to the declining influence of psychoanalytic approaches and the broader uncertainty surrounding the causes of autism. Decisions to adopt exclusion diets are sometimes influenced by written accounts from other parents. == Mechanism ==

: type 1 astrocytes surrounding blood capillaries in the brain GFCF diets for autistic individuals are sometimes motivated by the hypothesis of an imbalance in the gut microbiota, which is suspected to contribute to gastrointestinal symptoms. However, according to Robel et al., the reported prevalence of such symptoms among autistic children may be overestimated. A frequently cited causal explanation involves increased intestinal permeability, purportedly triggered by the consumption of gluten and casein. This hypothesis suggests that undigested peptides, toxins, and pro-inflammatory cytokines could cross the blood-brain barrier and influence brain function. A 1996 study by P. D'Eufemia and colleagues is often cited in support of this theory, reporting lower intestinal permeability in autistic children compared to non-autistic peers. Nonetheless, the scientific basis of this mechanism remains under debate. speculated that the low incidence of schizophrenia in certain South Pacific Island societies was a result of a diet low in wheat and milk-based foods. Dohan proposed a genetic defect wherein individuals are incapable of completely metabolizing gluten and casein as a possible cause for schizophrenia. Dohan hypothesized that elevated peptide levels from this incomplete metabolism could be responsible for schizophrenic behaviors. In 1979, Jaak Panksepp proposed a connection between autism and opiates, noting that injections of minute quantities of opiates in young laboratory animals induce symptoms similar to those observed among autistic children. Peptides were implicated in a 1982 study by Professor Christopher Gillberg, which suggested a possible link between peptide profiles and autism. However, these findings remain controversial, as a 1988 replication study by Le Couteur et al. did not identify a peptide profile specific to autistic individuals related to casein and gluten degradation. The possibility of a relationship between autism and the consumption of gluten and casein was first articulated by Kalle Reichelt in 1991. Based on studies showing correlation between autism, schizophrenia, and increased urinary peptide levels, Reichelt hypothesized that some of these peptides may have an opiate effect. This led to the development of the opioid excess theory, expounded by Paul Shattock and others, which speculates that peptides with opioid activity cross into the bloodstream from the lumen of the intestine, and then into the brain. These peptides were speculated to arise from incomplete digestion of certain foods, in particular gluten from wheat and certain other cereals and from casein from milk and dairy produce. Further work confirmed opioid peptides such as casomorphines (from casein) and gluten exorphines and gliadorphin (from gluten) as possible suspects, due to their chemical similarity to opiates. Reichelt hypothesized that long term exposure to these opiate peptides may have effects on brain maturation and contribute to social awkwardness and isolation. On this basis, Reichelt and others have proposed a gluten-free casein-free (GFCF) diet for those with autism to minimize the buildup of opiate peptides. The opioid peptide hypothesis is often cited to support the use of gluten- and casein-free diets in autism. As of 2020, this hypothesis remains unproven. No conclusive evidence has demonstrated an effect of gluten or casein on gastrointestinal symptoms in autistic children. According to Robel et al., the frequency of digestive disorders in autistic children is not significantly higher than in normal children, suggesting that the co-occurrence of these conditions may be coincidental rather than causally linked. Although isolated cases associate autism with celiac disease, no consistent or proven correlation has been established between autism and celiac disease or irritable bowel syndrome. The high prevalence of eating behavior disorders among autistic individuals has been identified as a potential factor contributing to digestive issues and imbalances in gut microbiota. == Efficacy studies ==

Studies on the effects of exclusion diets in the context of autism often exhibit significant heterogeneity and methodological limitations, such as small sample sizes and the absence of control groups. A 2021 review of 26 studies on autism and dietary interventions by Zainab Taha and Khalid A. Abdalhai found no conclusive evidence supporting the efficacy of exclusion diets. Additionally, emphasis on dietary approaches may divert financial and research resources from other potentially more effective interventions. Since the 1970s, studies have examined the effects of casein- and/or gluten-free diets on autistic individuals, A 2004 (updated in 2008) reported that current efficacy for these diets was poor but highlighted the need for further investigation. In 2006, a preliminary double-blind clinical trial involving 15 children aged 2 to 16 showed no statistically significant effects, although some parents reported behavioral improvements. In 2012, a survey of 387 parents who had implemented gluten-free and casein-free diets for their autistic children reported perceived behavioral improvements. However, a 2016 double-blind clinical trial involving 14 autistic children aged 3 to 5 did not demonstrate any significant effect from the dietary intervention. A first review of the scientific literature was conducted in 2010 by Dr. Austin Mulloy (University of Texas at Austin) and his team. Based on 15 previous studies, the review concluded: "A critical analysis of the methodological rigor and results of each study reveals that the current research body does not support the use of gluten-free and casein-free diets in treating ASD. Given the lack of empirical data and the often negative consequences associated with gluten-free diets [...] such diets should only be implemented if an autistic child exhibits acute behavioral changes that appear to be associated with dietary changes, and/or if healthcare professionals confirm through testing that the child has food allergies or intolerances to gluten and/or casein." In 2013, Dr. Timothy Buie of Boston Children's Hospital conducted a review of studies focusing on gluten and autism and concluded that the available evidence was insufficient to support the use of a gluten-free diet as a treatment for autism. In 2014, Dr. Salvador Marí-Bauset and his team at the University of Valencia published a review in the Journal of Child Neurology, stating that few studies offered strong scientific evidence. They recommended implementing gluten-free and casein-free diets only in cases where food intolerances or allergies had been medically diagnosed. The review also emphasized the need for future studies with more robust designs and larger sample sizes. In 2015, a review conducted by Klaus W. Lange and colleagues at the University of Regensburg, published in Current Opinion in Clinical Nutrition and Metabolic Care, reached conclusions consistent with previous reviews, finding insufficient evidence to support the use of gluten-free and casein-free diets as a treatment for autism. In 2020, Busra Baspinar and Hulya Yardimci (University of Ankara) published a review of the scientific literature on gluten-free and casein-free diets in autism. Consistent with previous studies, they concluded that the available research was limited in both quantity and quality, and that the effect of such diets on autistic behaviors remained unclear. • Cochrane Library – Gluten and Casein-free diets in autism spectrum disorder (2008). The Cochrane review found that while relatively commonly used the evidence to support the diets use in children with autism was poor. • Vanderbilt Evidence-based Practice Center – Therapies for Children with Autism Spectrum Disorder (2011). The review, commissioned by the Agency for Healthcare Research and Quality, concluded that, "the evidence supporting GFCF diets in ASD is limited and weak." • Clinical Therapeutics – The relationship of autism to gluten (2013). This review found one double-blind study, which did not find any benefit from the gluten-free diet, and concluded that "Currently, there is insufficient evidence to support instituting a gluten-free diet as a treatment for autism." • Journal of Child Neurology – Evidence of the Gluten-Free and Casein-Free Diet in Autism Spectrum Disorders: A Systematic Review (2014). This review found that "...the evidence on this topic is currently limited and weak," and noted that only a few randomized trials had been conducted on the efficacy of gluten-free diets as an autism treatment. The review also noted that even these trials were of questionable scientific merit because they were based on small sample sizes. • Current Opinion in Clinical Nutrition & Metabolic Care – Gluten-free and casein-free diets in the therapy of autism (2015). This review found "limited and weak" evidence that this diet was effective as a treatment for autism, noting that most studies that had been done to assess its effectiveness were "seriously flawed". • Autism Research Institute – The Autism Research Institute, an organization with a history of advocating unsupported hypotheses regarding autism, including that it can be caused by vaccines or treated with chelation therapy, recommends the GFCF/GFDF diet as a treatment for autism and related conditions. == Side effects ==

According to several studies, dietary interventions in autistic individuals are often perceived as harmless, particularly by parents of autistic children, while potential negative consequences may be underestimated, especially during the initial stages of implementation. Deficiencies and malnutrition According to Baspinar and Yardimci, long-term use of restrictive diets such as gluten-free and casein-free regimens may result in micronutrient deficiencies. Mulloy and colleagues reported reduced cortical bone thickness as a potential side effect following prolonged adherence to a casein-free diet in a child. can place additional demands on caregivers, particularly in terms of increased mental load and time required for meal preparation. Rochedy also observes that excluding gluten and casein may remove preferred foods from the diets of autistic children with high food selectivity, potentially worsening existing eating challenges. Testimonies cited by Olivia Cattan describe the emotional strain such dietary restrictions may place on families. == Official recommendations ==

The increase in the use of exclusion diets for autistic children led pediatricians from the French-speaking Group of Gastroenterology and Nutrition to request a review by the French Food Safety Agency (AFSSA). The French National Authority for Health advised against the use of exclusion diets in its 2012 report, a position also supported by the findings of Metz et al. (2005). In 2022, the United Kingdom's National Health Service included exclusion diets — including gluten-free and casein-free diets — on a list of alternative autism treatments it found showed no benefit and did not recommend to the public. == Promotion of exclusion diets ==

advertising campaign. In 2008 and 2014, the organization People for the Ethical Treatment of Animals (PETA) launched an English-language advertising campaign suggesting a link between milk consumption and autism. The campaign featured the slogan "Got autism?" alongside imagery referencing the earlier "Got Milk?" campaign. The initiative was criticized for lacking a scientific basis. In her 2015 book , Canadian author Nathalie Champoux claimed to have cured her two children of autism through dietary changes—eliminating milk, gluten, soy, and refined sugars—and chelation therapy. The book received criticism for promoting pseudoscientific claims, notably from the Association des communicateurs scientifiques du Québec, pediatrician Jean-François Chicoine of Sainte-Justine Hospital, and neuroscientist Laurent Mottron. According to Rochedy, some parents report reductions in autism-related symptoms and behavioral improvements in the initial days following the implementation of exclusion diets. In 2016, a family reported in the ''Revue Francophone d'Orthoptie'' that a diet excluding milk, gluten, and sugars had resolved their child's recurring ear infections. == See also ==